Melkersson-Rosenthal syndrome associated with parvovirus b19 viraemia and haemophagocytic lymphohistiocytosis

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  De Maria, A ^a,b   Zolezzi, A ^a   Passalacqua, G ^a   Leva, M ^a   Tarchino, F ^a   Spaggiari, P ^a   Balestracci, S ^a   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; ETOPOSIDE; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ERYTHEMA INFECTIOSUM; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOW DRUG DOSE; MALE; MELKERSSON ROSENTHAL SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

FATAL OUTCOME; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MELKERSSON-ROSENTHAL SYNDROME; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; SEVERITY OF ILLNESS INDEX; VIREMIA; YOUNG ADULT;

EID: 72549087532     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03337.x     Document Type: Article

References (10)

1. Ziem PE, Pfrommer C, Goerdt S et al. Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment. Br J Dermatol 2000 143 : 860 863.
2. Litviyakova LI, Bellanti JA. Orofacial edema: a diagnostic and therapeutic challenge for the clinician. Ann Allergy Asthma Immunol 2000 84 : 188 192.
3. Greene RM, Rogers RS III. Melkersson-Rosenthal syndrome: a review of 36 patients. J Am Acad Dermatol 1989 21 : 1263 1270.
4. Sciubba J, Nasser S. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med 2003 32 : 576 585.
5. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004 3 : 69 75.
6. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000 6 : 601 608.
7. Lefrere JJ, Servant-Delmas A, Candotti D et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 2005 106 : 2890 2895.
8. Magro CM, Crowson AN, Dawood M, Nuovo GJ. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol 2002 29 : 1227 1235.
9. Barash J, Dushnitzki D, Barak Y et al. Tumor necrosis factor (TNF) alpha and its soluble receptor (sTNFR) 75 during acute human parvovirus B19 infection in children. Immunol Lett 2003 88 : 109 112.
10. Lunardi C, Tiso M, Borgato L et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998 28 : 936 948.